Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Russo

Showing results (111-120 of 232) with videos related to

Pageof 24
Sort By:
European Journal of Clinical Pharmacology|March 17, 2025
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting SystemMaria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, et al.
Oncotarget|July 8, 2016
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53Valentina Pagliara, Assunta Saide, Emma Mitidieri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 27, 2024
Late-Stage Functionalization Using a Popular Titrating Agent: Aryl-Chlorides and -Fluorides Activation by the Diphenylacetic Acid DianionAlessandro Cerveri, Giulia Russo, Sara Sparascio, et al.
Scientific Data|May 31, 2025
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation datasetFrancesco Guarnera, Alessia Rondinella, Elena Crispino, et al.
International Journal of Molecular Sciences|December 30, 2020
S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer CellsLaura Mosca, Martina Pagano, Annalisa Pecoraro, et al.
Biochimica Et Biophysica Acta. General Subjects|September 25, 2016
Backbone modified TBA analogues endowed with antiproliferative activityVeronica Esposito, Annapina Russo, Teresa Amato, et al.
NPJ Digital Medicine|November 17, 2025
Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologiesFrancesca Pistollato, Fabia Furtmann, Lindsay J Marshall, et al.
Cancers|March 29, 2023
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting SystemMaria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, et al.
Bioorganic Chemistry|December 1, 2017
The "Janus face" of the thrombin binding aptamer: Investigating the anticoagulant and antiproliferative properties through straightforward chemical modificationsVeronica Esposito, Annapina Russo, Teresa Amato, et al.
Nucleic Acids Research|December 3, 2020
Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivativesAntonella Virgilio, Veronica Esposito, Annalisa Pecoraro, et al.
Pageof 24

Showing results (111-120 of 232) with videos related to

Sort By:
Pageof 24
European Journal of Clinical Pharmacology|March 17, 2025
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting SystemMaria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, et al.
Oncotarget|July 8, 2016
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53Valentina Pagliara, Assunta Saide, Emma Mitidieri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 27, 2024
Late-Stage Functionalization Using a Popular Titrating Agent: Aryl-Chlorides and -Fluorides Activation by the Diphenylacetic Acid DianionAlessandro Cerveri, Giulia Russo, Sara Sparascio, et al.
Scientific Data|May 31, 2025
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation datasetFrancesco Guarnera, Alessia Rondinella, Elena Crispino, et al.
International Journal of Molecular Sciences|December 30, 2020
S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer CellsLaura Mosca, Martina Pagano, Annalisa Pecoraro, et al.
Biochimica Et Biophysica Acta. General Subjects|September 25, 2016
Backbone modified TBA analogues endowed with antiproliferative activityVeronica Esposito, Annapina Russo, Teresa Amato, et al.
NPJ Digital Medicine|November 17, 2025
Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologiesFrancesca Pistollato, Fabia Furtmann, Lindsay J Marshall, et al.
Cancers|March 29, 2023
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting SystemMaria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, et al.
Bioorganic Chemistry|December 1, 2017
The "Janus face" of the thrombin binding aptamer: Investigating the anticoagulant and antiproliferative properties through straightforward chemical modificationsVeronica Esposito, Annapina Russo, Teresa Amato, et al.
Nucleic Acids Research|December 3, 2020
Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivativesAntonella Virgilio, Veronica Esposito, Annalisa Pecoraro, et al.
Pageof 24